DC

DCVC Bio — Pre-Seed & Seed VC Firm ($500K–$25.0M Checks)

VC
Palo Alto, CA, United StatesWebsite

DCVC Bio is a Pre-Seed, Seed venture capital firm based in Palo Alto, CA, United States investing in Healthcare, AI / ML, Other. The firm typically writes $500K–$25.0M checks and has 10 portfolio companies in our records.

Check size
$500K–$25.0M
Portfolio
10 companies on record
Partners
7 listed
AUM
$1.2B
Stage
Pre-Seed, Seed
Sectors
Healthcare, AI / ML, Other
HQ
Palo Alto, CA, United States

Last verified: 2026-09-09

How to approach: warm intro preferred
Stage

Pre-Seed, Seed

Check Size

$500K – $25.0M

AUM

$1.2B

Portfolio

10+ companies

Team

7 partners

Investor activity
Last known investment: 2026Investments in last 12 months: 4

Investment Thesis

DCVC Bio invests in founders who combine deep biological insight and engineering with large-scale computation (AI, data, etc.) to build platform-driven technologies in human health, agriculture, and bio-based materials and sustainable food systems.

How DCVC Bio invests

DCVC Bio is a vc firm based in Palo Alto, CA, United States. The firm invests at the Pre-Seed, Seed stages, with a focus on Healthcare, AI / ML, Other.

DCVC Bio typically writes checks of $500K–$25.0M per investment, backed by approximately $1.2B in assets under management.

Investing since at least 2014, DCVC Bio has backed 10 companies in our records, including Noetik, Radiant, Unlearn. Its most recent recorded investment was in 2026, with 4 investments logged over the last 12 months.

Partners & Team

SP

Spencer Punter

Chief Operating Officer

AT

Ali Tamaseb

General Partner

RW

Ryan Ward

Chief Legal Officer

FC

Flo Chialtas

Talent Acquisition Partner

MO

Matt Ocko

Co-Managing Partner

HealthTech
AI
Deep Tech
AC

Alan Cohen

General Partner

JP

Jason Pontin

General Partner

Industry Focus

Invests In

Healthcare
AI / ML
Other

Portfolio Companies (10)

2026

NO

Noetik

AI cancer models

RA

Radiant

Boosts round to $350M amid nuclear fervor

UN

Unlearn

RE

Recursion Pharmaceuticals

AI revolution in drugmaking

2024

LA

Latus Bio

Finding precisely tuned viral vectors for gene therapy in CNS disorders

2022

FE

Fervo Energy

Tapping into the heat beneath our feet to provide gigawatts of clean energy

2021

RE

Relation

Using machine learning to understand the biology underlying disease

2014

PI

Pivot Bio

Reprogramming soil microbes to produce nitrogen sustainably

Other

RE

Recursion Pharma

HealthTech
EL

Elegen

Life Sciences
How to pitch DCVC Bio
  • •Raising at Pre-Seed, Seed? You're squarely in their sweet spot.
  • •Lead with your fit in Healthcare, AI / ML, Other — the sectors they actively back.
  • •Size your ask to their typical $500K – $25.0M check.
  • •warm intro preferred
  • •Address your outreach to a specific partner, such as Spencer Punter, Chief Operating Officer.
  • •A warm introduction beats a cold email. Get matched and request an intro.

Featured In

Browse More Investors

Fundraising resources

Frequently Asked Questions

See if DCVC Bio is a match for your startup

Upload your pitch deck to see how well you match with DCVC Bio and 10,000+ other investors.

Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT

Is this your profile? Request a correction or removal